Literature DB >> 3829421

Development and validation of an improved radioimmunoassay for serotonin in platelet-rich plasma.

I F Gow, J E Corrie, B C Williams, C R Edwards.   

Abstract

A radioimmunoassay (RIA) using a 125I-tracer is described for measurement of serotonin (5-hydroxytryptamine, 5-HT) in human platelet-rich plasma (PRP). Antisera were raised against 5-HT-succinamate conjugated to bovine albumin and, to improve assay sensitivity, the analyte was made chemically similar to the immunogen by conversion to N-acetylserotonin prior to assay, using the specific amino reagent N-acetoxysuccinimide. The assay shows good correlation with a high-pressure liquid chromatography (HPLC) reference method (5-HT RIA = 1.007 X 5-HT HPLC + 29.3, r = 0.936, p less than 0.001, n = 40), indicating that no significant cross-reactions were detected. Samples of PRP are diluted 1/20 to fall within the working range (80-15% B/B0) of the assay, which is 4.75-325 nmol/l, (0.95-65.0 pmol/tube), corresponding to 95-6500 nmol/l in PRP. Intra- and interassay coefficients of variation were 5.0-10.5% and 12.0-21.2% respectively for serotonin concentrations of 250-2,500 nmol/l added to platelet-poor plasma. With this improved assay, it is possible to analyse up to 100 samples/day, compared with 10-20 samples/day by HPLC.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3829421     DOI: 10.1016/0009-8981(87)90449-9

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  6 in total

1.  Native serotonin membrane receptors recognize 5-hydroxytryptophan-functionalized substrates: enabling small-molecule recognition.

Authors:  Amit Vaish; Mitchell J Shuster; Sarawut Cheunkar; Yogesh S Singh; Paul S Weiss; Anne M Andrews
Journal:  ACS Chem Neurosci       Date:  2010-04-09       Impact factor: 4.418

2.  Smoking, hypertension, and colonic anastomotic healing; a combined clinical and histopathological study.

Authors:  A Fawcett; M Shembekar; J S Church; R Vashisht; R G Springall; D M Nott
Journal:  Gut       Date:  1996-05       Impact factor: 23.059

3.  Blood and urine 5-hydroxytryptophan and 5-hydroxytryptamine levels after administration of two 5-hydroxytryptamine precursors in normal man.

Authors:  T C Wa; N J Burns; B C Williams; S Freestone; M R Lee
Journal:  Br J Clin Pharmacol       Date:  1995-03       Impact factor: 4.335

4.  The effects of alpha 2-adrenoceptor antagonists on the inhibition of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced head shakes by 5-HT1A receptor agonists in the mouse.

Authors:  S M Dursun; S L Handley
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

5.  A lack of effect of captopril on platelet aggregation in patients with congestive heart failure.

Authors:  I F Gow; A D Flapan; M Morris; E Davies; B C Williams; P L Padfield; T R Shaw; C R Edwards
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

6.  The sensitivity of human blood platelets to the aggregating agent ADP during different dietary sodium intakes in healthy men.

Authors:  I F Gow; M Dockrell; C R Edwards; A Elder; J Grieve; G Kane; P L Padfield; C J Waugh; B C Williams
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.